Policy & Regulation
Gemini BioProducts names new director
17 March 2023 -

Gemini BioProducts Holding, Inc. (GeminiBio), a portfolio company of BelHealth Investment Partners, LLC (BelHealth), announced on Thursday that it has named Gopi Natarajan as its new director.

Natarajan has over thirty-five years of leadership experience in the healthcare industry. He co-Founded Omega Healthcare and held the position of chief executive officer for 18 years.

Harold S. Blue, Managing Partner of BelHealth Investment Partners, said, 'I have known Gopi for over 25 years and our predecessor fund was the first institutional investor in Omega back in 2006 and is now the leading RCM company backed by Goldman Sachs and Everstone Capital. He has stellar leadership and operational skills and will assist the GeminiBio team execute during its imminent growth phase. I am looking forward to working closely with Gopi again.'